from:
http://www.abc.net.au/4corners/content/2003/20030811_patent/default.htm
4Cornes looked more specifically at an Australian company that has some wide ranging patents over 'junk' DNA.
http://www.abc.net.au/4corners/content/2003/20030811_patent/default.htm
Every day, worldwide, laboratories routinely analyse human genes to pinpoint a whole range of suspected diseases. Life-saving treatment can depend on fast, accurate diagnoses.
Tests like these cost a lot of money. And now corporations are moving to cash in.
It's a development that deeply worries some scientists who fear the public good is falling victim to private profit. Are the public health benefits of speedy diagnoses and groundbreaking research being jeopardised in a rush for a biotech bonanza?
4Cornes looked more specifically at an Australian company that has some wide ranging patents over 'junk' DNA.